Neogenomics Inc (NEO)

R&D Expense Growth

12.87%

Quarterly · Period ending:

NEO logo

NEO R&D Expense Growth

Latest reported12.87%
NEO Quarterly R&D Growth (QoQ) (0.00% → 12.87%)
High-resolution chart · PNG

NEO r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Neogenomics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
12.8697%
3.8675%
5.5786%
-3.6462%
-11.3741%
27.7576%
3.709%
-2.5615%
3.4908%
6.9174%
34.8534%
-29.5521%
1.4469%
10.7865%
-8.7117%
-43.4318%
2.4816%
48.1616%
14.9008%
111.9886%
42.3046%
16.9524%
6.9246%
-6.6983%
2.1845%
-0.9615%
-20.337%
0.9277%
113.9785%
129.8479%
17.9372%
-58.4343%
12.2385%
71.9424%
-56.2205%
34.1077%
9.8608%
-7.3118%
-3.8263%
-25.9571%
-9.6819%
-22.0905%
113.0884%
8.4682%
20.0299%
61.5942%
-59.1716%
60.1896%
0.7962%
-3.2357%
90.8824%
-44.8052%
-26.2275%
86.3839%
-44.5545%
53.0303%
6.2374%
0%
-100%
-27.3256%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
-100%
-33.1234%
-19.8847%
-13.9133%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.